The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Viral Genome Sequencing Market In 2026, And How Will Its Value Evolve By 2030?
The viral genome sequencing market size has seen swift expansion in recent years. Forecasts indicate it will expand from $6.71 billion in 2025 to reach $7.72 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 14.9%. Historically, this expansion has been driven by factors such as an increasing frequency of viral outbreaks, the widespread adoption of next-generation sequencing, the development of clinical diagnostics, financial backing from governments for research, and the need for epidemiological studies.
The viral genome sequencing market size is anticipated to experience substantial expansion over the coming years. Its valuation is projected to reach $13.57 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This growth throughout the forecast period stems from factors such as AI-driven genome analysis, the broadening of vaccine development initiatives, the uptake of portable sequencing technologies, their integration with predictive bioinformatics, and a heightened emphasis on real-time pathogen monitoring. Key developments expected during this period encompass high-throughput viral genome sequencing, the use of portable sequencing devices, integration with bioinformatics platforms, streamlined automated sample processing, and continuous real-time mutation tracking.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Drivers Are Fueling The Growth Of The Viral Genome Sequencing Market?
The expanding occurrence of infectious diseases is projected to fuel the advancement of the viral genome sequencing market in the future. These diseases, stemming from pathogenic microorganisms, are seeing a continuous global increase, driven by factors like intensified international travel, urban expansion, and the swift transnational spread of pathogens. This escalating burden of illness has prompted governments and healthcare infrastructures to enhance their genomic surveillance and outbreak response capabilities. Viral genome sequencing is crucial in managing infectious diseases, facilitating the quick identification of viral strains, monitoring genetic changes, tracing transmission routes, and aiding focused public health strategies. As an illustration, in February 2026, data from the US-based government department, Centers for Disease Control and Prevention (CDC), indicated that in 2026, influenza led to roughly 290,000–450,000 hospitalizations and 34,000–53,000 deaths each year in the United States. Concurrently, RSV was responsible for an estimated 190,000–350,000 hospitalizations and 10,000–23,000 deaths. Consequently, the rising occurrence of infectious diseases is anticipated to spur the expansion of the viral genome sequencing market.
What Are The Main Segments Within The Viral Genome Sequencing Market Segment Structure?
The viral genome sequencing market covered in this report is segmented –
1) By Sequencing Technology: Next-Generation Sequencing, Sanger Sequencing, Third-Generation Sequencing
2) By Sample Type: Blood, Nasal Or Throat Swabs, Saliva, Other Sample Types
3) By Application: Clinical Diagnostics, Research, Epidemiology, Vaccine Development, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Next-Generation Sequencing: Sequencing By Synthesis, Ion Semiconductor Sequencing, Reversible Terminator Chemistry Sequencing, Targeted Amplicon Sequencing, Whole Genome Shotgun Sequencing
2) By Sanger Sequencing: Capillary Electrophoresis Sequencing, Automated Fluorescent Chain Termination Sequencing, Dideoxy Chain Termination Sequencing, Low Throughput Mutation Verification Sequencing, Plasmid Insert Verification Sequencing
3) By Third-Generation Sequencing: Single Molecule Real Time Sequencing, Nanopore Based Sequencing, Zero Mode Waveguide Sequencing, Long Read Direct Ribonucleic Acid Sequencing, Real Time Field Deployable Sequencing
Which Trends Are Shaping The Viral Genome Sequencing Market?
Leading companies in the viral genome sequencing market are prioritizing technological advancements in long-read sequencing, such as benchtop long-read sequencing platforms, to gain a competitive advantage. A benchtop long-read sequencing platform is an integrated laboratory system designed to generate highly accurate, extended nucleotide reads from viral genomes within a compact footprint, facilitating comprehensive structural variant detection, improved genome assembly, and faster turnaround for pathogen characterization. This strengthens surveillance capabilities, supports outbreak response, and enhances research precision, albeit requiring higher capital investment and advanced data analysis infrastructure at scale. For instance, in November 2024, Pacific Biosciences, a US-based biotechnology company, introduced the Revio benchtop HiFi sequencing platform. This platform delivers high-fidelity long reads, increased throughput compared with earlier systems, and a scalable configuration for clinical and research laboratories, improving viral mutation tracking and genome completeness in the viral genome sequencing market.
Who Are The Companies Participating In The Viral Genome Sequencing Market?
Major companies operating in the viral genome sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Twist Bioscience Corporation, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Genewiz, Macrogen Inc., MedGenome Labs Ltd., Eurofins Scientific SE, CD Genomics, BGI Genomics Co. Ltd.
Get The Full Viral Genome Sequencing Market Report:
https://www.thebusinessresearchcompany.com/report/viral-genome-sequencing-market-report
Which Region Leads The Viral Genome Sequencing Market In Terms Of Market Share?
North America was the largest region in the viral genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral genome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Viral Genome Sequencing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Viral Genome Sequencing Market 2026, By The Business Research Company
pruritus therapeutic market report 2026
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report
genomic urine testing market report 2026
https://www.thebusinessresearchcompany.com/report/genomic-urine-testing-global-market-report
ocular genetic diagnostic market report 2026
https://www.thebusinessresearchcompany.com/report/ocular-genetic-diagnostic-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model